Entreprise · 11/11/20261 min de lecture
Dutch Biotech fighting ALS and other neuro-degenerative diseases gets European backing
Traduction automatique locale · Langue originale de la source
Résumé
The European Investment Bank (EIB) has signed a €30 million convertible loan agreement with Amsterdam-based VectorY Therapeutics, a clinical-stage biotechnology company developing a novel treatment for…